These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 37896791)

  • 21. HPV16/18 prevalence in high-grade cervical lesions in an Australian population offered catch-up HPV vaccination.
    Cornall AM; Saville M; Pyman J; Callegari ET; Tan FH; Brotherton JML; Malloy MJ; Tabrizi SN; Wrede CD; Garland SM;
    Vaccine; 2020 Sep; 38(40):6304-6311. PubMed ID: 32736938
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Age and geographic variability of human papillomavirus high-risk genotype distribution in a large unvaccinated population and of vaccination impact on HPV prevalence.
    Carozzi F; De Marco L; Gillio-Tos A; Del Mistro A; Girlando S; Baboci L; Trevisan M; Burroni E; Grasso S; Giorgi Rossi P; Ronco G;
    J Clin Virol; 2014 Jul; 60(3):257-63. PubMed ID: 24815381
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Respective prevalence of high-risk HPVgenotypes in cervical neoplasia in Senegal.
    Diop-Ndiaye H; Sastre-Garau X; Drame A; Dembele B; Ba NN; Diop-Diongue O; Mbow M; Diakhaby MEB; Woto-Gaye G; Toure Kane C; Diop M
    J Med Virol; 2021 Aug; 93(8):5110-5117. PubMed ID: 33851737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of HPV vaccination with Gardasil® in Switzerland.
    Jacot-Guillarmod M; Pasquier J; Greub G; Bongiovanni M; Achtari C; Sahli R
    BMC Infect Dis; 2017 Dec; 17(1):790. PubMed ID: 29273004
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HPV prevalence and genotype distribution among women in Shandong Province, China: Analysis of 94,489 HPV genotyping results from Shandong's largest independent pathology laboratory.
    Jiang L; Tian X; Peng D; Zhang L; Xie F; Bi C; Wang R; Wang J; Qi D
    PLoS One; 2019; 14(1):e0210311. PubMed ID: 30653566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of type-specific human papillomavirus infection among women in France: Implications for screening, vaccination, and a future generation of multivalent HPV vaccines.
    Monsonego J; Zerat L; Syrjänen K; Zerat JC; Smith JS; Halfon P
    Vaccine; 2012 Jul; 30(35):5215-21. PubMed ID: 22713720
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of over ten years of HPV vaccination in England: Surveillance of type-specific HPV in young sexually active females.
    Checchi M; Mesher D; Panwar K; Anderson A; Beddows S; Soldan K
    Vaccine; 2023 Oct; 41(45):6734-6744. PubMed ID: 37821315
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cervical cancer in Ethiopia: a review of the literature.
    Derbie A; Mekonnen D; Nibret E; Misgan E; Maier M; Woldeamanuel Y; Abebe T
    Cancer Causes Control; 2023 Jan; 34(1):1-11. PubMed ID: 36242682
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Public health impact and cost-effectiveness of switching from bivalent to nonavalent vaccine for human papillomavirus in Norway: incorporating the full health impact of all HPV-related diseases.
    Diakite I; Nguyen S; Sabale U; Pavelyev A; Saxena K; Tajik AA; Wang W; Palmer C
    J Med Econ; 2023; 26(1):1085-1098. PubMed ID: 37608730
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of high-risk Human Papillomavirus genotyping in cervical disease in the Northern region of Portugal: Real-world data from regional cervical cancer screening program.
    Rosário A; Sousa A; Marinho-Dias J; Medeiros R; Lobo C; Leça L; Coimbra N; Tavares F; Baldaque I; Martins G; Monteiro P; Henrique R; Sousa H
    J Med Virol; 2023 Jan; 95(1):e28414. PubMed ID: 36541747
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distribution of HPV Genotype in Invasive Cervical Carcinoma and Cervical Intraepithelial Neoplasia in Zhejiang Province, Southeast China: Establishing the Baseline for Surveillance.
    Xu XX; Zhou JS; Yuan SH; Yu H; Lou HM
    Int J Environ Res Public Health; 2015 Sep; 12(9):10794-805. PubMed ID: 26404339
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.
    Rogovskaya SI; Shabalova IP; Mikheeva IV; Minkina GN; Podzolkova NM; Shipulina OY; Sultanov SN; Kosenko IA; Brotons M; Buttmann N; Dartell M; Arbyn M; Syrjänen S; Poljak M
    Vaccine; 2013 Dec; 31 Suppl 7():H46-58. PubMed ID: 24332297
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence and distribution of high-risk Human Papillomavirus in Western Türkiye between 2019 and 2022.
    Ece GT; Pira D; Bodur GL
    Acta Microbiol Immunol Hung; 2023 Sep; 70(3):252-257. PubMed ID: 37347660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Racial/ethnic variation in the prevalence of vaccine-related human papillomavirus genotypes.
    Montealegre JR; Varier I; Bracamontes CG; Dillon LM; Guillaud M; Sikora AG; Follen M; Adler-Storthz K; Scheurer ME
    Ethn Health; 2019 Oct; 24(7):804-815. PubMed ID: 28870103
    [No Abstract]   [Full Text] [Related]  

  • 35. Human papillomavirus genotypic characteristics of 60,685 subjects under age-expansion vaccination of the nine-valent human papillomavirus vaccine: A cross-sectional study.
    Liu Y; Li Z; Yuan L; Liu F; Wu K; Xiao X; Zhu C
    J Infect Public Health; 2023 Jul; 16(7):989-995. PubMed ID: 37167646
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence and genotype-specific distribution of human papillomavirus in Burundi according to HIV status and urban or rural residence and its implications for control.
    Ndizeye Z; Vanden Broeck D; Lebelo RL; Bogers J; Benoy I; Van Geertruyden JP
    PLoS One; 2019; 14(6):e0209303. PubMed ID: 31237894
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study.
    de Sanjose S; Quint WG; Alemany L; Geraets DT; Klaustermeier JE; Lloveras B; Tous S; Felix A; Bravo LE; Shin HR; Vallejos CS; de Ruiz PA; Lima MA; Guimera N; Clavero O; Alejo M; Llombart-Bosch A; Cheng-Yang C; Tatti SA; Kasamatsu E; Iljazovic E; Odida M; Prado R; Seoud M; Grce M; Usubutun A; Jain A; Suarez GA; Lombardi LE; Banjo A; Menéndez C; Domingo EJ; Velasco J; Nessa A; Chichareon SC; Qiao YL; Lerma E; Garland SM; Sasagawa T; Ferrera A; Hammouda D; Mariani L; Pelayo A; Steiner I; Oliva E; Meijer CJ; Al-Jassar WF; Cruz E; Wright TC; Puras A; Llave CL; Tzardi M; Agorastos T; Garcia-Barriola V; Clavel C; Ordi J; Andújar M; Castellsagué X; Sánchez GI; Nowakowski AM; Bornstein J; Muñoz N; Bosch FX;
    Lancet Oncol; 2010 Nov; 11(11):1048-56. PubMed ID: 20952254
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of human papillomavirus genotypes in cytologic abnormalities from unvaccinated women living in north-western Spain.
    Otero-Motta AP; Ordóñez JL; González-Celador R; Rivas B; Macías Mdel C; Bullón A; Abad Mdel M
    APMIS; 2011 Mar; 119(3):204-15. PubMed ID: 21284738
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human papillomavirus genotypes among females in Mexico: a study from the Mexican institute for social security.
    Salcedo M; Pina-Sanchez P; Vallejo-Ruiz V; Monroy-Garcia A; Aguilar-Lemarroy A; Cortes-Gutierrez EI; Santos-Lopez G; Montoya-Fuentes H; Grijalva R; Madrid-Marina V; Apresa-Garcia T; Hernandez DM; Jave-Suarez LF; Romero P; Poot A; Salgado E; Ramos-Gonzalez P; Gonzalez-Hernandez R; Canton JC; Jimenez-Aranda L; Parra-Melquiadez M; Paniagua L; Mendoza M; Arreola H; Villegas V; Torres-Poveda K; Bahena-Roman M; Gonzalez-Yebra B; Taniguchi K; Rodea C; Mantilla-Morales A; Mora-Garcia ML; Velazquez-Velazquez CK; Cordova-Uscanga C; Peralta R; Lopez-Romero R; Marrero D; Bandala C; Reyes-Leyva J; Furuya ME; Almeida E; Galvan ME; Grijalva I
    Asian Pac J Cancer Prev; 2014; 15(23):10061-6. PubMed ID: 25556426
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of cervicovaginal human papillomavirus infection and genotypes in the pre-vaccine era in China: A nationwide population-based study.
    Bao HL; Jin C; Wang S; Song Y; Xu ZY; Yan XJ; Li LM; Ning Y; Wang HJ
    J Infect; 2021 Apr; 82(4):75-83. PubMed ID: 33610682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.